Umantod, Charmaine E.

HRN: 27-35-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CEFUROXIME 1.5GM (VIAL)
06/23/2025
06/25/2025
IV
1.5gm
Q8hrx 3doses
Sp NSVD With RMLE; PROM
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines